
Food processing and aviation equipment manufacturer JBT Marel (NYSE: JBTM) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.9% year on year to $981 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.03 billion at the midpoint. Its non-GAAP profit of $1.95 per share was 3.4% below analysts’ consensus estimates.
Is now the time to buy JBT Marel? Find out by accessing our full research report, it’s free.
JBT Marel (JBTM) Q2 CY2026 Highlights:
- Revenue: $981 million vs analyst estimates of $982.2 million (4.9% year-on-year growth, in line)
- Adjusted EPS: $1.95 vs analyst expectations of $2.02 (3.4% miss)
- Adjusted EBITDA: $168 million vs analyst estimates of $167.7 million (17.1% margin, in line)
- The company reconfirmed its revenue guidance for the full year of $4.03 billion at the midpoint
- Management lowered its full-year Adjusted EPS guidance to $8.10 at the midpoint, a 1.8% decrease
- Operating Margin: 4.7%, in line with the same quarter last year
- Free Cash Flow Margin: 7.1%, down from 9.4% in the same quarter last year
- Backlog: $1.54 billion at quarter end, up 10% year on year
- Market Capitalization: $7.21 billion
Company Overview
Tracing back to its invention of the mechanical milk bottle filler in 1884, JBT Marel (NYSE: JBTM) designs, manufactures, and sells equipment used for food processing and aviation.
Revenue Growth
Examining a company’s long-term performance can provide clues about its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Thankfully, JBT Marel’s 17.5% annualized revenue growth over the last five years was incredible. Its growth surpassed the average industrials company and shows its offerings resonate with customers, a great starting point for our analysis.

Long-term growth is the most important, but within industrials, a half-decade historical view may miss new industry trends or demand cycles. JBT Marel’s annualized revenue growth of 54.6% over the last two years is above its five-year trend, suggesting its demand was strong and recently accelerated. 
This quarter, JBT Marel grew its revenue by 4.9% year on year, and its $981 million of revenue was in line with Wall Street’s estimates.
Looking ahead, sell-side analysts expect revenue to grow 5% over the next 12 months, a deceleration versus the last two years. This projection doesn’t excite us and indicates its products and services will see some demand headwinds. At least the company is tracking well in other measures of financial health.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
Operating Margin
JBT Marel’s operating margin has risen over the last 12 months and averaged 6.8% over the last five years. Although its profitability is still mediocre, we can see its elite revenue growth is giving it operating leverage as it scales. This gives it a shot at higher long-term profits if it can keep expanding.
Looking at the trend in its profitability, JBT Marel’s operating margin might have fluctuated slightly but has generally stayed the same over the last five years. This raises questions about the company’s expense base because its revenue growth should have given it leverage on its fixed costs, resulting in better economies of scale and profitability.

In Q2, JBT Marel generated an operating margin profit margin of 4.7%, in line with the same quarter last year. This indicates the company’s cost structure has recently been stable.
Earnings Per Share
Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth — for example, a company could inflate its sales through excessive spending on advertising and promotions.
JBT Marel’s EPS grew at a remarkable 13.6% compounded annual growth rate over the last five years. However, this performance was lower than its 17.5% annualized revenue growth, telling us the company became less profitable on a per-share basis as it expanded.

Diving into the nuances of JBT Marel’s earnings can give us a better understanding of its performance. A five-year view shows JBT Marel has diluted its shareholders, growing its share count by 62.6%. This has led to lower per share earnings. Taxes and interest expenses can also affect EPS but don’t tell us as much about a company’s fundamentals. 
Like with revenue, we analyze EPS over a shorter period to see if we are missing a change in the business.
For JBT Marel, its two-year annual EPS growth of 30% was higher than its five-year trend. We love it when earnings growth accelerates, especially when it accelerates off an already high base.
In Q2, JBT Marel reported adjusted EPS of $1.95, up from $1.49 in the same quarter last year. Despite growing year on year, this print missed analysts’ estimates, but we care more about long-term adjusted EPS growth than short-term movements. Over the next 12 months, Wall Street expects JBT Marel’s full-year EPS to grow 19.9% from $7.45 to $8.93.
Key Takeaways from JBT Marel’s Q2 Results
We struggled to find many positives in these results. Its full-year EPS guidance missed and its EPS fell short of Wall Street’s estimates. Overall, this was a weaker quarter. The stock traded down 3.7% to $137 immediately after reporting.
JBT Marel didn’t show its best hand this quarter, but does that create an opportunity to buy the stock right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here (it’s free).
